For the major U.S. GLP-1 brands people ask about for weight loss, Wegovy, Ozempic, Zepbound and Mounjaro, do not assume there is a true FDA-approved generic equivalent. A compounded semaglutide or tirzepatide product is not a generic. A generic must be FDA-approved, listed through FDA drug approval systems, and manufactured under drug-approval standards.
Key takeaways
- A true generic is FDA-approved; a compounded product is not the same thing.
- Compounded GLP-1 products may be legal in limited situations, but FDA says they are not reviewed for safety, effectiveness or quality before marketing.
- FDA has warned about fraudulent compounded GLP-1 products, dosing errors and salt forms of semaglutide.
- Foreign or “Canada generic” claims need extra caution because U.S. legality and product quality may not match the claim.
- Lower-cost options should start with official savings programs, coverage routes and approved alternatives.
Generic vs compounded: the key difference
A generic drug is not just “same active ingredient, cheaper.” In the U.S., a generic is approved by FDA through a drug application pathway and must meet standards for identity, strength, quality, purity and performance. It is usually connected to the FDA Orange Book for small-molecule drugs and has formal approval status.
A compounded drug is different. It is prepared by a pharmacy or outsourcing facility for a patient need. Compounding can be important in medicine, but compounded drugs are not FDA-approved and are not the same as generics. FDA says compounded GLP-1 drugs should only be used when a patient’s medical needs cannot be met by an FDA-approved drug.
| Term | What it means | What it is not |
|---|---|---|
| FDA-approved generic | Approved generic version of a drug | Not simply any cheaper product with a similar ingredient |
| Compounded GLP-1 | Prepared by a compounder for a medical need | Not FDA-approved and not automatically equivalent |
| Research peptide | Often sold outside prescription drug channels | Not a legitimate consumer treatment route |
| Foreign “generic” | May refer to a product outside U.S. approval systems | Not automatically lawful, safe or FDA-approved for U.S. patients |
Why people think a generic exists
There are three reasons. First, many people use “generic” casually to mean any lower-cost version. Second, compounded products exploded during GLP-1 shortages and were often marketed with language that blurred the line. Third, international search results can show products or names from other countries that do not map neatly to U.S. approvals.
That confusion matters because it changes risk. A true FDA-approved generic has gone through an approval process. A compounded product has not. A research vial may sit outside the drug supply chain entirely. Treating those as the same category is unsafe.
What FDA has warned about
FDA’s GLP-1 compounding page lists several current concerns: fraudulent compounded semaglutide and tirzepatide with false labels, pharmacies named on labels that did not actually make the product, dosing errors with compounded injectable semaglutide, use of semaglutide salt forms that differ from the active ingredient in approved drugs, and adverse event reports related to compounded semaglutide and tirzepatide.
FDA has also clarified policies as national GLP-1 supply stabilizes and proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, saying it had not identified a clinical need for outsourcing facilities to compound those substances from bulk drug substances. The practical message for consumers is not “all compounding is fake.” The message is: do not assume compounded equals generic, FDA-approved, or interchangeable.
Safer lower-cost options
- Check official savings programs. Manufacturer terms change, but official pages are the right starting point.
- Check coverage by indication. Diabetes-branded and weight-management-branded drugs can be covered differently.
- Use legitimate telehealth carefully. Look for licensed prescribers, named pharmacies and clear product sourcing.
- Ask about approved alternatives. Older GLP-1s or non-GLP medications may fit some people better financially.
- Appeal insurance denials. If you have insurance but were denied, documentation and appeal strategy can matter.
Bottom line
If a seller says “generic Ozempic,” “generic Wegovy,” “generic Mounjaro,” or “generic Zepbound,” slow down. Ask whether it is FDA-approved as a generic, whether it appears in official FDA systems, who manufactures it, which pharmacy dispenses it, and whether your prescriber specifically chose it for your medical situation. If those answers are vague, do not treat the product as a generic.
Frequently asked questions
Is there a generic Ozempic or Wegovy?
Do not assume there is a true FDA-approved generic equivalent for major GLP-1 brands. Check FDA approval resources such as Drugs@FDA and the Orange Book for the current status before relying on any “generic” claim.
Is compounded semaglutide a generic?
No. Compounded semaglutide is not the same as an FDA-approved generic. FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed.
What about generic GLP-1 from Canada?
Be cautious. A foreign product or international search result is not automatically lawful, FDA-approved, or safe for U.S. patients. Discuss any medication source with a clinician and use licensed pharmacies.
How can I lower GLP-1 cost safely?
Start with official manufacturer savings programs, insurance appeals, legitimate telehealth or local care, and approved alternatives. Avoid no-prescription vials and research peptides.